Breaking News Instant updates and real-time market news.

SMMT

Summit Therapeutics

$1.85

(0.00%)

04:55
10/16/18
10/16
04:55
10/16/18
04:55

Summit Therapeutics management to meet with Oppenheimer

Meeting to be held in New York on October 16 hosted by Oppenheimer.

  • 16

    Oct

  • 17

    Oct

SMMT Summit Therapeutics
$1.85

(0.00%)

06/28/18
JMPS
06/28/18
DOWNGRADE
JMPS
Market Perform
Summit Therapeutics downgraded to Market Perform at JMP Securities
06/28/18
JANY
06/28/18
DOWNGRADE
JANY
Neutral
Summit Therapeutics downgraded to Neutral from Buy at Janney Montgomery Scott
06/28/18
RHCO
06/28/18
DOWNGRADE
Target $4
RHCO
Hold
Summit Therapeutics downgraded to Hold at SunTrust on failed phase 2 DMD study
As reported earlier, SunTrust analyst Edward Nash downgraded Summit Therapeutics to Hold from Buy and lowered his price target to $4 from $22. The analyst cites the company's failed phase 2 study on Duchenne muscular dystrophy treatment as its stock price plunged nearly 80% intraday, adding that Summit will now discontinue ezutromid development and focus on the antibiotic program for C difficile infection. Nash further notes that the company's new lead product candidate, Ridinilazole, is now expected to enter phase 3 trials in Q1 of FY19.
06/29/18
HCWC
06/29/18
NO CHANGE
Target $3
HCWC
Buy
Summit Therapeutics price target lowered to $3 from $20 at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay lowered his price target for Summit Therapeutics to $3 after the company discontinued the development of ezutromid upon the full analysis of the 48-week data. Summit is now leveraged to its Phase 3 ready, differentiated, novel, gut flora sparing antibiotic for the treatment of Clostridium difficile, Chattopadhyay tells investors in a research note. Unfortunately, the Phase 3 program is not expected to commence until Q1 of 2019 and may not readout until 2021, the analyst adds. He believes, however, that the "damage to the stock is already done with the company trading at cash." Chattopadhyay sees "no value in moving to the sidelines" and keeps a Buy rating on Summit.

TODAY'S FREE FLY STORIES

SCI

Service Corp.

$42.31

-0.42 (-0.98%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Hot Stocks
Service Corp. raises quarterly cash dividend 6% to 18c per share »

Service Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
02/21/19
02/21
11:16
02/21/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

GS

Goldman Sachs

$197.12

-1.49 (-0.75%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Initiation
Goldman Sachs initiated  »

Odeon's Dick Bove…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 03

    Mar

  • 12

    Mar

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

DK

Delek US

$36.95

-0.13 (-0.35%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Options
Delek US draws upside call buyers as shares slip off early highs »

Delek US draws upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Existing home sales fell 1.2% in January to 4.99 M, a 3-year low »

Existing home sales fell…

11:08
02/21/19
02/21
11:08
02/21/19
11:08
General news
3-Month Bill Announcement CUSIP Number data reported »

3-Month Bill Announcement…

MNST

Monster Beverage

$58.64

-0.07 (-0.12%)

11:07
02/21/19
02/21
11:07
02/21/19
11:07
Options
Monster Beverage option volume spikes to 3X daily average amid active trading »

Monster Beverage option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

LIVN

LivaNova

$98.56

-1.32 (-1.32%)

11:07
02/21/19
02/21
11:07
02/21/19
11:07
Recommendations
LivaNova analyst commentary  »

Piper says Japanese…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

  • 07

    May

  • 08

    May

  • 09

    May

UBCP

United Bancorp

$10.95

(0.00%)

11:04
02/21/19
02/21
11:04
02/21/19
11:04
Hot Stocks
United Bancorp raises quarterly cash dividend to 13.25c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIVN

LivaNova

$98.59

-1.29 (-1.29%)

11:03
02/21/19
02/21
11:03
02/21/19
11:03
Hot Stocks
LivaNova announces national reimbursement in Japan for Perceval valve for AVD »

LivaNova announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

  • 07

    May

  • 08

    May

  • 09

    May

KO

Coca-Cola

$45.48

0.36 (0.80%)

11:03
02/21/19
02/21
11:03
02/21/19
11:03
Hot Stocks
Coca-Cola announces new share repurchase program for up to 150M shares »

The Coca-Cola board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 03

    Mar

KO

Coca-Cola

$45.49

0.37 (0.82%)

11:02
02/21/19
02/21
11:02
02/21/19
11:02
Hot Stocks
Coca-Cola raises quarterly dividend to 40c per share from 39c per share »

The Coca-Cola board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 03

    Mar

11:00
02/21/19
02/21
11:00
02/21/19
11:00
General news
EIA natural gas storage change for week ending February 15 »

Earlier, gas inventories…

11:00
02/21/19
02/21
11:00
02/21/19
11:00
General news
Crude inventories for week of February 15 »

Crude oil inventories…

KR

Kroger

$28.82

0.07 (0.24%)

11:00
02/21/19
02/21
11:00
02/21/19
11:00
Options
One-day call buyers in Kroger »

One-day call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 07

    Mar

UAA

Under Armour

$21.26

-0.02 (-0.09%)

, UA

Under Armour

$19.22

0.025 (0.13%)

10:52
02/21/19
02/21
10:52
02/21/19
10:52
Periodicals
Under Armour CEO questioned by board about ties with MSNBC anchor, WSJ says »

A number of current and…

UAA

Under Armour

$21.26

-0.02 (-0.09%)

UA

Under Armour

$19.22

0.025 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

10:50
02/21/19
02/21
10:50
02/21/19
10:50
General news
U.S. corporate bond update: issuance continues apace today »

U.S. corporate bond…

COUP

Coupa Software

$92.39

-1.36 (-1.45%)

10:50
02/21/19
02/21
10:50
02/21/19
10:50
Options
Short-term hedge opened in Coupa Software »

Short-term hedge opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 12

    Mar

10:50
02/21/19
02/21
10:50
02/21/19
10:50
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

OHRP

Ohr Pharmaceutical

$2.01

(0.00%)

10:47
02/21/19
02/21
10:47
02/21/19
10:47
Hot Stocks
Ohr Pharmaceutical regains compliance with Nasdaq listing requirements »

Ohr Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$5.81

4.385 (307.72%)

, MRK

Merck

$79.79

0.35 (0.44%)

10:46
02/21/19
02/21
10:46
02/21/19
10:46
Downgrade
Immune Design, Merck rating change  »

Immune Design downgraded…

IMDZ

Immune Design

$5.81

4.385 (307.72%)

MRK

Merck

$79.79

0.35 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 11

    Apr

  • 18

    May

  • 17

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.